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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection none
Data analysis Code used in creating the designed sequence and in analysis is described in the methods, where links to the Github repository are 
provided (http://github.com/TiongSun/genome_recoding)(http://github.com/TiongSun/recoding_landscape). These links will be made 
available upon publication. This code was made available to reviewers and editors during review.  
Publicly available software bowtie2 2.3.2, samtools 1.3.1, iSeq (http://github.com/TiongSun/iSeq), Integrative Genomics Viewer 2.4, ueye 
cockpit software 4.91.1, Nikon NIS elements 4.50.00, MaxQuant 1.5.5.1, Perseus 1.5.5.3, and Fiji  were used for data analysis. 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The sequences and genome design details used in this study are available in 
the Supplementary Data. Supplementary Data 1 provides the GenBank file of the 
E. coli MDS42 genome (NCBI accession number AP012306.1); Supplementary 
Data 2 provides the GenBank file of designed synthetic E. coli genome with 
codon replacements and refactorings; Supplementary Data 3 provides the table of 
target codons; Supplementary Data 4 provides the table of overlaps and refactoring; 
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Supplementary Data 5 provides the table of 10-kb stretches; Supplementary 
Data 6 provides the GenBank file of the BAC sacB-cat-rpsL; Supplementary 
Data 7 provides the GenBank file of BAC-rpsL-kanR-sacB; Supplementary Data 8 
provides the GenBank file of the BAC rpsL-kanR-pheS?-HygR; Supplementary 
Data 9 provides the table of BAC construction; Supplementary Data 10 provides 
the table of BAC assembly; Supplementary Data 11 provides the table of REXER 
experiments; Supplementary Data 12 provides the GenBank file of spacer plasmids 
without trans-activating CRISPR RNA (tracrRNA) and annotation for linear 
spacers; Supplementary Data 13 provides the GenBank file of spacer plasmids with 
tracrRNA and annotation for linear spacers; Supplementary Data 14 provides the 
table of oligonucleotides used for recoding fixing experiments; Supplementary 
Data 15 provides the GenBank file of the gentamycin-resistance oriT cassette; 
Supplementary Data 16 provides the oligonucleotide primers used for conjugation; 
Supplementary Data 17 provides the GenBank file of the pJF146 Fʹ plasmid 
that does not self-transfer; Supplementary Data 18 provides the GenBank 
file of the fully recoded genome of Syn61, verified by next-generation sequencing; 
Supplementary Data 19 provides the table of design optimizations and nonprogrammed 
mutations; Supplementary Data 20 provides a list of the proteins 
identified by tandem mass spectrometry; and Supplementary Data 21 provides a 
list of the primers used for deletion experiments. All other datasets generated and/ 
or analysed in this study are available from the corresponding author on reasonable 
request. All materials (Supplementary Data 9, 12, 13, 17, 18) from this study are 
available from the corresponding author upon reasonable request. 
Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No sample-size calculation was performed. Because the variation in the assays used is small and we are interested in large effects, the sample 
sizes used, as indicated in the manuscript, were deemed appropriate. 
Data exclusions There are no data exclusions
Replication The exact number of replicates is stated in the relevant legend. All attempts at replication were successful.
Randomization No randomization. This is not relevant because the samples form defined groups. 
Blinding No blinding. Blinding is not relevant to the study. The groups were defined and studied by the investigator using standard protocols. 
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems
n/a Involved in the study
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Clinical data
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
